ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Health Technology

Eiken Chemical Co., Ltd.

  • 2,415.00 JPY
  • -8.00
  • -0.33%
  • Japan
    Nov 15, 2018
  • Ticker
    TKS(4549)
  • Prev. close
    2,423
  • Market cap (JPY)
    105,500.91M
  • Market cap (USD)
    926.29M
  • Shares
    43.54M

Business Summary

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. It operates through Clinical Diagnostics and Testing of Food and Environment business divisions. The Clinical Diagnostics division handles the manufacture of clinical diagnostic products and services. The Testing of Food and Environment division deals with the sale of reagents for microbiological tests on food for poisoning bacteria, and environment for contamination of work environments. Its products include automated fecal occult blood analyzer, real time turbidimeter, amplification kits, fluorescence detection reagent, detection kits and culture media. The company was founded on February 20, 1939 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue34,989M315.69M
Gross Profit14,691M132.55M
Operating income3,471M31.31M
Income before tax3,474M31.34M
Net income2,608M23.53M
EBITDA5,131M46.29M
Diluted EPS70.310.63
Dividends Per Share250.22
Total Assets45,165M424.68M
Total liabilities12,684M119.26M
Total equity32,478M305.38M
Operating cash flow4,091M36.91M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 30,027M 31,014M 32,163M 33,274M 34,989M
Gross Profit 12,366M 12,858M 13,393M 14,156M 14,691M
Operating income 2,997M 2,817M 3,527M 3,970M 3,471M
Income before tax 3,059M 3,004M 3,390M 3,845M 3,474M
Net income 1,984M 2,100M 2,429M 2,918M 2,608M
EBITDA 4,111M 4,070M 4,957M 5,533M 5,131M
Diluted EPS 53.92 56.92 65.70 78.78 70.31
Dividends Per Share 17.50 17.50 20 25 25
Total Assets 36,395M 37,895M 39,266M 44,252M 45,165M
Total liabilities 12,117M 11,256M 11,065M 13,641M 12,684M
Total equity 24,278M 26,639M 28,201M 30,609M 32,478M
Operating cash flow 3,410M 3,393M 3,115M 4,701M 4,091M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 299.75M 282.31M 267.83M 307.27M 315.69M
Gross Profit 123.44M 117.04M 111.52M 130.72M 132.55M
Operating income 29.91M 25.64M 29.37M 36.66M 31.31M
Income before tax 30.53M 27.34M 28.23M 35.50M 31.34M
Net income 19.80M 19.11M 20.22M 26.94M 23.53M
EBITDA 41.03M 37.04M 41.27M 51.09M 46.29M
Diluted EPS 0.53 0.51 0.54 0.72 0.63
Dividends Per Share 0.17 0.15 0.16 0.23 0.22
Total Assets 353.40M 315.98M 349.35M 397.12M 424.68M
Total liabilities 117.65M 93.85M 98.44M 122.41M 119.26M
Total equity 235.74M 222.13M 250.90M 274.69M 305.38M
Operating cash flow 34.04M 30.88M 25.94M 43.41M 36.91M

Valuation Measures

Mar 2018
PER37.64
ROA5.83%
ROE8.26%
Operating margin9.92%
Profit margin7.45%

Key executives

  • President & Representative Director: Morifumi Wada
  • Director, Manager-Research & Development: Tsugunori Noutomi
  • Executive Officer & Senior Manager-Sales: Yutaka Sekiguchi
  • Executive Officer: Tsutomu Naito
  • Executive Officer & Senior Manager-Production: Kazuhisa Ueda

Shareholders

  • Eiken Chemical Co., Ltd. (15.8%)
  • Otsuka Holdings Co., Ltd. (9.1%)
  • Matthews International Capital Management LLC (8.7%)
  • FIL Investments (Japan) Ltd. (7.0%)
  • Asset Management One Co., Ltd. (6.4%)
  • Sumitomo Mitsui Asset Management Co., Ltd. (5.2%)
  • T. Rowe Price International Ltd. (4.6%)
  • KUROZUMI TADAO (2.9%)
  • Dai-ichi Life Holdings, Inc. (2.5%)
  • Norges Bank Investment Management (1.9%)

Contact Details

  • Website:http://www.eiken.co.jp
  • Address: Yamaguchi Building, 7/F, 4-19-9 Taito, Tokyo, 110-8408, Japan
  • Phone: +81.3.5846.3305

Related Companies

  • Eiken Chemical Co. Ltd. (Europe Office)
  • Eiken China Co. Ltd.
  • Eken Million Staff
  • Eiken Chemical Employee Stock Ownership Plan

Competitors

    Last Updated on 15 Nov, 2018

    You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

    Subscribe to get unlimited access to all articles.

    Get unlimited access
    NAR site on phone, device, tablet

    {{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

    Stay ahead with our exclusives on Asia; the most dynamic market in the world.

    Benefit from in-depth journalism from trusted experts within Asia itself.

    Try 3 months for $9

    Offer ends September 30th

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to the Nikkei Asian Review has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media